Jocelyn de Heer

1.0k total citations
20 papers, 752 citations indexed

About

Jocelyn de Heer is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Jocelyn de Heer has authored 20 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Molecular Biology. Recurrent topics in Jocelyn de Heer's work include Diabetes Treatment and Management (8 papers), Pancreatic function and diabetes (6 papers) and Metabolism, Diabetes, and Cancer (4 papers). Jocelyn de Heer is often cited by papers focused on Diabetes Treatment and Management (8 papers), Pancreatic function and diabetes (6 papers) and Metabolism, Diabetes, and Cancer (4 papers). Jocelyn de Heer collaborates with scholars based in Germany, Denmark and United States. Jocelyn de Heer's co-authors include Jens J. Holst, C.E. Rasmussen, D.H. Coy, Burkhard Göke, Asger Lund, Mikkel Christensen, Filip K. Knop, Urd Kielgast, Berit Svendsen and Mette M. Rosenkilde and has published in prestigious journals such as Diabetes, Gut and Diabetologia.

In The Last Decade

Jocelyn de Heer

18 papers receiving 738 citations

Peers

Countries citing papers authored by Jocelyn de Heer

Since Specialization

Citations

This map shows the geographic impact of Jocelyn de Heer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyn de Heer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyn de Heer more than expected).

Fields of papers citing papers by Jocelyn de Heer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jocelyn de Heer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyn de Heer. The network helps show where Jocelyn de Heer may publish in the future.

Co-authorship network of co-authors of Jocelyn de Heer

This figure shows the co-authorship network connecting the top 25 collaborators of Jocelyn de Heer. A scholar is included among the top collaborators of Jocelyn de Heer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jocelyn de Heer. Jocelyn de Heer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Universal submucosal dissection outperforms selective mucosal resection in early esophageal adenocarcinoma 2026 ·Endoscopy ·(unknown), T Rösch, (unknown), Hanno Ehlken, (unknown), (unknown), Till S. Clauditz, (unknown), Jocelyn de Heer, Yuki B. Werner, (unknown), (unknown), Oliver Mann, (unknown), Susanne Sehner, (unknown), Guido Schachschal	0
2	Nasal Continuous Positive Airway Pressure to Reduce Hypoxia in Patients With Obesity Undergoing Sedated Upper Gastrointestinal Endoscopy: A Prospective Randomized Trial 2025 ·Clinical Gastroenterology and Hepatology ·(unknown), Christian Sprenger, Christian Zöllner, Jocelyn de Heer, Moritz von Wulffen, Katharina Zimmermann, Thomas Rösch, Malte Issleib	0
3	Laparoscopic lymph node sampling: a new concept for patients with high-risk early esophagogastric junction cancer resected endoscopically 2021 ·Gastrointestinal Endoscopy ·Anna Duprée, Hanno Ehlken, Thomas Rösch, (unknown), Matthias Reeh, Yuki B. Werner, Jocelyn de Heer, Guido Schachschal, Till S. Clauditz, Oliver Mann, Jakob R. Izbicki, Stefan Groth	3
4	Prevalence and risk factors of undiagnosed diabetes mellitus among gastroenterological patients: a HbA1c-based single center experience – Prevalence of undiagnosed diabetes in gastroenterological patients 2021 ·Zeitschrift für Gastroenterologie ·Thorben Fründt, (unknown), Angelique Hölzemer, Hans O. Pinnschmidt, Jocelyn de Heer, (unknown), Thomas Renné, Anne Lautenbach, Ansgar W. Lohse, Jörg Schrader	2
5	The value of CT imaging and CRP quotient for detection of postbariatric complications 2020 ·Langenbeck s Archives of Surgery ·Anna Duprée, Jocelyn de Heer, (unknown), Tarik Ghadban, Oliver Mann, Katharina Grupp, Hans O. Pinnschmidt, Jakob R. Izbicki, Stefan Wolter	4
6	Histologic and Clinical Effects of Different Topical Corticosteroids for Eosinophilic Esophagitis: Lessons from an Updated Meta-Analysis of Placebo-Controlled Randomized Trials 2020 ·Digestion ·Jocelyn de Heer, Stephan Miehlke, Thomas Rösch, Andrea Morgner, Yuki B. Werner, Hanno Ehlken, Heiko Becher, Annette Aigner	12
7	Hyperammonemia by Ureaplasma urealyticum Pneumonia after Lung Transplantation 2020 ·Respiratory Medicine Case Reports ·(unknown), Markus J. Barten, Jocelyn de Heer, (unknown), Daniel Frings, Stefan Kluge	12
8	Pneumatic balloon dilatation versus laparoscopic Heller myotomy for achalasia: a failed attempt at meta-analysis 2020 ·Surgical Endoscopy ·Jocelyn de Heer, Madhav Desai, Guy E. Boeckxstaens, Giovanni Zaninotto, Karl–Hermann Fuchs, Prateek Sharma, Guido Schachschal, Oliver Mann, Thomas Rösch, Yuki B. Werner	11
9	Decreased Frequency of Intestinal CD39+ γδ+ T Cells With Tissue-Resident Memory Phenotype in Inflammatory Bowel Disease 2020 ·Frontiers in Immunology ·(unknown), (unknown), Marcus Kantowski, (unknown), Johanna M. Eberhard, Jocelyn de Heer, (unknown), Samuel Huber, Friedrich Haag, Julian Schulze zur Wiesch	15
10	Designs of colonoscopic adenoma detection trials: more positive results with tandem than with parallel studies - an analysis of studies on imaging techniques and mechanical devices 2020 ·Gut ·(unknown), Heiko Pohl, Thomas Rösch, Douglas K. Rex, Cesare Hassan, Evelien Dekker, Michał F. Kamiński, Michael Bretthauer, Jocelyn de Heer, Yuki B. Werner, Guido Schachschal, Stefan Groth	15
11	Are incretin mimetics and enhancers linked to pancreatitis and malignant transformations in pancreas? 2014 ·Expert Opinion on Drug Safety ·Jocelyn de Heer, Burkhard Göke	15
12	Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade 2013 ·Diabetes ·Benedikt A. Aulinger, (unknown), (unknown), Jocelyn de Heer, Jens J. Holst, Burkhard Göke, Jörg Schirra	78
13	Adipositas, metabolisches Syndrom und Krebsentstehung 2012 ·Der Diabetologe ·Jocelyn de Heer	1
14	Regulation of glucagon secretion by incretins 2011 ·Diabetes Obesity and Metabolism ·Jens J. Holst, Mikkel Christensen, Asger Lund, Jocelyn de Heer, Berit Svendsen, Urd Kielgast, Filip K. Knop	117
15	Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas 2008 ·Diabetologia ·Jocelyn de Heer, C.E. Rasmussen, D.H. Coy, Jens J. Holst	191
16	The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas 2007 ·Diabetologia ·Jocelyn de Heer, Jens Pedersen, Cathrine Ørskov, Jens J. Holst	49
17	Sulfonylurea Compounds Uncouple the Glucose Dependence of the Insulinotropic Effect of Glucagon-Like Peptide 1 2007 ·Diabetes ·Jocelyn de Heer, Jens J. Holst	90
18	GIP-(3–42) does not antagonize insulinotropic effects of GIP at physiological concentrations 2006 ·American Journal of Physiology-Endocrinology and Metabolism ·Carolyn F. Deacon, Astrid Plamboeck, Mette M. Rosenkilde, Jocelyn de Heer, Jens J. Holst	58
19	Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor γ (PPARγ) gene and type 2 diabetes 2001 ·Experimental and Clinical Endocrinology & Diabetes ·D. Gareth Evans, Jocelyn de Heer, (unknown), Dorte Wendt, Alexander M. Wolf, Ulrike Beisiegel, (unknown)	42
20	Variation in the gene for human peroxisome proliferator activated receptor γ (PPARγ) does not play a major role in the development of morbid obesity 2000 ·International Journal of Obesity ·D. Gareth Evans, W. Alexander Mann, Jocelyn de Heer, Uwe Michel, Dorte Wendt, (unknown), Alexander M. Wolf, Ulrike Beisiegel	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact